Then, we knocked down the level of MOB1A in miR‐664a‐3p inhibitor cells, as expected, we concluded that decline of MOB1A eliminated the impact of miR‐664a‐3p inhibition on GC cells migration (Figure 4A,B). The gene discussed is MOB1A; the disease is gastric cancer.